NORDIX DNA ApS: Financial statements 2020
CVR: 36908130
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
NORDIX DNA ApS (CVR 36908130) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,969 and a net result of DKK -7,158 compared with DKK -1,000 the year before. Equity in the 2020 report amounted to DKK -14,173. The company had 1 employee in the financial year.
- Gross Profit
- DKK -3,969
- Profit/Loss
- DKK -7,158
- Equity
- DKK -14,173
- Total Assets
- DKK 40,014
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -4 t. | -7 t. | -14 t. | 1 |
| 2019 | - | -1 t. | -1 t. | -7 t. | 1 |
| 2018 | - | -2 t. | -2 t. | -6 t. | 1 |
| 2017 | - | 0 | 0 | -4 t. | 1 |
Official annual report
How creditworthy is NORDIX DNA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of March 31, 2020, Casper Holm Mulberg is registered as director of NORDIX DNA ApS.
As of March 31, 2020, Tommy Walther Larsson has stepped down as director of NORDIX DNA ApS.
On March 31, 2020, the company changed its name from FAB.DK IVS to NORDIX DNA IVS.
As of March 31, 2020, NORDIX HOLDING ApS is registered as an owner of NORDIX DNA ApS with an ownership share of 100%.
NORDIX DNA ApS has published its annual report for 2019. Gross profit came to DKK -1,000, and the net result was DKK -1,000.
About NORDIX DNA ApS
NORDIX DNA ApS is a Danish company of the type Anpartsselskab based in Frederikshavn, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named NORDIX DNA IVS and FAB.DK IVS. The management consists of Casper Holm Mulberg. The company is owned by NORDIX HOLDING ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.